期刊
PLOS ONE
卷 5, 期 1, 页码 -出版社
PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0008785
关键词
-
资金
- California Institute for Regenerative Medicine
- American Society of Hematology (ASH)
- Burroughs Wellcome Fund
- National Institutes of Health (NIH) [1RO1HL092471-01, 1RO1HL088582-01, R01CA086017, R01HL058770, R01CA086065, P01DK053074]
- California Institute for Regenerative Medicine (CIRM)
- Department of Biomolecular Engineering, University of California Santa Cruz
- National Science Foundation's Division of Biological Infrastructure [DBI-0543197]
- Alfred P. Sloan Foundation
Hematopoietic stem cells (HSC) are rare, multipotent cells capable of generating all specialized cells of the blood system. Appropriate regulation of HSC quiescence is thought to be crucial to maintain their lifelong function; however, the molecular pathways controlling stem cell quiescence remain poorly characterized. Likewise, the molecular events driving leukemogenesis remain elusive. In this study, we compare the gene expression profiles of steady-state bone marrow HSC to non-self-renewing multipotent progenitors; to HSC treated with mobilizing drugs that expand the HSC pool and induce egress from the marrow; and to leukemic HSC in a mouse model of chronic myelogenous leukemia. By intersecting the resulting lists of differentially regulated genes we identify a subset of molecules that are downregulated in all three circumstances, and thus may be particularly important for the maintenance and function of normal, quiescent HSC. These results identify potential key regulators of HSC and give insights into the clinically important processes of HSC mobilization for transplantation and leukemic development from cancer stem cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据